Equities

Lumos Diagnostics Holdings Ltd

Lumos Diagnostics Holdings Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.055
  • Today's Change-0.002 / -3.51%
  • Shares traded1.23m
  • 1 Year change+205.56%
  • Beta--
Data delayed at least 20 minutes, as of Apr 26 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • LDX:ASX trading volume exceeds daily average by +50.15%
  • LDX:ASX price moved over +8.93% to 0.061
  • LDX:ASX price rises above 15-day moving average to 0.062 at 11:06 BST

Key statistics

On Friday, Lumos Diagnostics Holdings Ltd (LDX:ASX) closed at 0.055, 450.00% above the 52 week low of 0.01 set on Jun 30, 2023.
52-week range
Today
0.01Jun 30 20230.175Jul 04 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.056
High0.057
Low0.055
Bid0.055
Offer0.057
Previous close0.057
Average volume2.84m
Shares outstanding481.31m
Free float335.51m
P/E (TTM)--
Market cap26.47m AUD
EPS (TTM)-0.0364
AUD
Data delayed at least 20 minutes, as of Apr 26 2024 07:10 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.